drugset / Trial / NCT07348640

Evaluation of the Efficacy and Safety of Magnetic Resonance Angiography (MRA) Using Gadopiclenol Compared to Gadoterate Meglumine in the Assessment of Steno-occlusive Disease in Adult Patients With Suspected Vascular Disease

NCT07348640

Phase 3 Not yet recruiting 315 enrolled Guerbet Bracco Imaging S.p.A. · collab
RandomizedCrossoverQuadruple-blindDiagnostic

Summary

Compare the diagnostic performance of gadopiclenol against gadoterate meglumine in patients with vascular diseases of supra-aortic, peripheral, or abdominal / renal arteries using MRI

Timeline

Start
2026-02-02
Primary completion
2027-12-31
Completion
2027-12-31

Drugs

EvaluationDrugModalityDoseRoute
Subject Gadopiclenol Diagnostic / imaging agent 0.1 unknown
Subject Gadoterate meglumine Diagnostic / imaging agent 0.1 unknown

Indications